tiprankstipranks
Advertisement
Advertisement
Ionis Pharmaceuticals price target raised to $76 from $72 at JPMorgan
PremiumThe FlyIonis Pharmaceuticals price target raised to $76 from $72 at JPMorgan
24d ago
McCormick, Wabtec, Ecolab, Ionis, Fastenal Insider Shock
Premium
Weekend Updates
McCormick, Wabtec, Ecolab, Ionis, Fastenal Insider Shock
26d ago
Ionis Pharmaceuticals: Strong Commercial Momentum and Late‑Stage Pipeline Catalysts Drive Buy Rating
Premium
Ratings
Ionis Pharmaceuticals: Strong Commercial Momentum and Late‑Stage Pipeline Catalysts Drive Buy Rating
28d ago
Ionis Pharmaceuticals announces chief scientific officer Bennett to retire
PremiumThe FlyIonis Pharmaceuticals announces chief scientific officer Bennett to retire
29d ago
Ionis Pharmaceuticals reports Q2 EPS (69c), consensus (88c)
Premium
The Fly
Ionis Pharmaceuticals reports Q2 EPS (69c), consensus (88c)
29d ago
Is IONS a Buy, Before Earnings?
Premium
Pre-Earnings
Is IONS a Buy, Before Earnings?
1M ago
Ionis Pharmaceuticals downgraded to Peer Perform from Outperform at Wolfe Research
PremiumThe FlyIonis Pharmaceuticals downgraded to Peer Perform from Outperform at Wolfe Research
1M ago
Ionis Pharmaceuticals call volume above normal and directionally bullish
Premium
The Fly
Ionis Pharmaceuticals call volume above normal and directionally bullish
1M ago
Ionis says Biogen presents Phase 2 CELIA data at AAIC
Premium
The Fly
Ionis says Biogen presents Phase 2 CELIA data at AAIC
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100